Literature DB >> 7806564

The v-sis oncoprotein loses transforming activity when targeted to the early Golgi complex.

K C Hart1, Y F Xu, A N Meyer, B A Lee, D J Donoghue.   

Abstract

The location of autocrine interactions between the v-sis protein and PDGF receptors remains uncertain and controversial. To examine whether receptor-ligand interactions can occur intracellularly, we have constructed fusion proteins that anchor v-sis to specific intracellular membranes. Fusion of a cis-Golgi retention signal from a coronavirus E1 glycoprotein to v-sis protein completely abolished its transforming ability when transfected into NIH3T3 cells. Fusion proteins incorporating mutations in this retention signal were not retained within the Golgi complex but instead were transported to the cell surface, resulting in efficient transformation. All chimeric proteins were shown to dimerize properly. Derivatives of some of these constructs were also constructed bearing the cytoplasmic tail from the glycoprotein of vesicular stomatitis virus (VSV-G). These constructs allowed examination of subcellular localization by double-label immunofluorescence, using antibodies that distinguish between the extracellular PDGF-related domain and the VSV-G cytoplasmic tail. Colocalization of sis-E1-G with Golgi markers confirmed its targeting to the early Golgi complex. The sis-E1 constructs, targeted to the early Golgi complex, exhibited no proteolytic processing whereas the mutant forms of sis-E1 exhibited normal proteolytic processing. Treatment with suramin, a polyanionic compound that disrupts ligand/receptor interactions at the cell surface, was able to revert the transformed phenotype induced by the mutant sis-E1 constructs described here. Our results demonstrate that autocrine interactions between the v-sis oncoprotein and PDGF receptors within the early Golgi complex do not result in functional signal transduction. Another v-sis fusion protein was constructed by attaching the transmembrane domain and COOH-terminus of TGN38, a protein that localizes to the trans-Golgi network (TGN). This construct was primarily retained intracellularly, although some of the fusion protein reached the surface. Deletion of the COOH-terminal region of the TGN38 retention signal abrogated the TGN-localization, as evidenced by very prominent cell surface localization, and resulted in increased transforming activity. The behavior of the sis-TGN38 derivatives is discussed within the context of the properties of TGN38 itself, which is known to recycle from the cell surface to the TGN.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7806564      PMCID: PMC2120273          DOI: 10.1083/jcb.127.6.1843

Source DB:  PubMed          Journal:  J Cell Biol        ISSN: 0021-9525            Impact factor:   10.539


  63 in total

1.  Transformation-specific interaction of the bovine papillomavirus E5 oncoprotein with the platelet-derived growth factor receptor transmembrane domain and the epidermal growth factor receptor cytoplasmic domain.

Authors:  B D Cohen; D J Goldstein; L Rutledge; W C Vass; D R Lowy; R Schlegel; J T Schiller
Journal:  J Virol       Date:  1993-09       Impact factor: 5.103

2.  Intracellular turnover, novel secretion, and mitogenically active intracellular forms of v-sis gene product in simian sarcoma virus-transformed cells. Implications for intracellular loop autocrine transformation.

Authors:  V B Lokeshwar; S S Huang; J S Huang
Journal:  J Biol Chem       Date:  1990-01-25       Impact factor: 5.157

3.  Retention of a cis Golgi protein requires polar residues on one face of a predicted alpha-helix in the transmembrane domain.

Authors:  C E Machamer; M G Grim; A Esquela; S W Chung; M Rolls; K Ryan; A M Swift
Journal:  Mol Biol Cell       Date:  1993-07       Impact factor: 4.138

4.  The trans-Golgi network can be dissected structurally and functionally from the cisternae of the Golgi complex by brefeldin A.

Authors:  M S Ladinsky; K E Howell
Journal:  Eur J Cell Biol       Date:  1992-10       Impact factor: 4.492

5.  TGN38/41 recycles between the cell surface and the TGN: brefeldin A affects its rate of return to the TGN.

Authors:  B Reaves; M Horn; G Banting
Journal:  Mol Biol Cell       Date:  1993-01       Impact factor: 4.138

6.  TGN38 is maintained in the trans-Golgi network by a tyrosine-containing motif in the cytoplasmic domain.

Authors:  K Bos; C Wraight; K K Stanley
Journal:  EMBO J       Date:  1993-05       Impact factor: 11.598

7.  Intracellular retention of membrane-anchored v-sis protein abrogates autocrine signal transduction.

Authors:  B A Lee; D J Donoghue
Journal:  J Cell Biol       Date:  1992-09       Impact factor: 10.539

8.  Localization of TGN38 to the trans-Golgi network: involvement of a cytoplasmic tyrosine-containing sequence.

Authors:  J S Humphrey; P J Peters; L C Yuan; J S Bonifacino
Journal:  J Cell Biol       Date:  1993-03       Impact factor: 10.539

9.  The BPV-1 E5 protein, the 16 kDa membrane pore-forming protein and the PDGF receptor exist in a complex that is dependent on hydrophobic transmembrane interactions.

Authors:  D J Goldstein; T Andresson; J J Sparkowski; R Schlegel
Journal:  EMBO J       Date:  1992-12       Impact factor: 11.598

10.  A brefeldin A-like phenotype is induced by the overexpression of a human ERD-2-like protein, ELP-1.

Authors:  V W Hsu; N Shah; R D Klausner
Journal:  Cell       Date:  1992-05-15       Impact factor: 41.582

View more
  3 in total

1.  Neoplasia driven by mutant c-KIT is mediated by intracellular, not plasma membrane, receptor signaling.

Authors:  Zhifu Xiang; Frederike Kreisel; Jennifer Cain; AnnaLynn Colson; Michael H Tomasson
Journal:  Mol Cell Biol       Date:  2006-10-23       Impact factor: 4.272

2.  E5 oncoprotein retained in the endoplasmic reticulum/cis Golgi still induces PDGF receptor autophosphorylation but does not transform cells.

Authors:  J Sparkowski; J Anders; R Schlegel
Journal:  EMBO J       Date:  1995-07-03       Impact factor: 11.598

3.  Exosomal vaccines containing the S protein of the SARS coronavirus induce high levels of neutralizing antibodies.

Authors:  Seraphin Kuate; Jindrich Cinatl; Hans Wilhelm Doerr; Klaus Uberla
Journal:  Virology       Date:  2007-01-26       Impact factor: 3.616

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.